Algenex
OverviewSuggest Edit
Algenex is a biotechnology company developing technologies to support the production of recombinant proteins using Baculovirus vector expression systems (BVES) in insect cells. It specializes in the production of subunit vaccines utilizing proprietary technologies CrisBio and TopBac.
| Type | Private | |
| Founded | 2005 | |
| HQ | Madrid, ES | Map |
| Website | algenex.com |
Recent NewsAll News
- Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics
- Algenex enters biocomponents market to provide mammalian-free production of cost efficient high-quality proteins and peptides
- Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease
- Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication
Latest Updates
| Employees (est.) (Jan 2022) | 25 |
Key People/Management at Algenex
José Escribano
Founder and CSO
Virginia Gonzalez
CFO
Romy Dalton
COO
Algenex Office Locations
Algenex has an office in Madrid
Madrid, ES (HQ)
Universidad Politécnica de Madrid, Av. de Montepríncipe
Algenex Financials and Metrics
Summary Metrics
Founding Date | 2005 |
Algenex Online and Social Media Presence
Algenex's Trends
Algenex News and Updates
November 18, 2021
Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics
PRESS RELEASE
September 24, 2020
Algenex inaugurates new facility with capacity to produce up to 100 million vaccine doses
Algenex inaugurates new facility with capacity to produce up to 100 million vaccine doses
Algenex Blogs
September 30, 2021
Algenex enters biocomponents market to provide mammalian-free production of high-quality proteins and peptides at reduced cost
Proven technology poised to accelerate emergence and growth of cell-based meat space.
June 14, 2021
Call notice for a shareholders’ meeting of ALTERNATIVE GENE EXPRESSION, S.L.
The managing body of ALTERNATIVE GENE EXPRESSION, S.L. (the “Company”), in accordance with the statutory and bylaw provisions in force, has resolved to call the shareholders of the Company to a shareholders’ meeting, to be held by conference call on 29 June 2021, at 11:00 am, to deliberate and decid…
June 08, 2021
Open position: Technician Downstream Area
Are you ready to take the leap with us? Here are our current job openings.
March 12, 2021
Be part of Algenex story
Are you ready to take the leap with us? Here are our current job openings.
February 12, 2021
We participate in Bio€quity Forum (May 17-19, 2021)
Bio€quity is the most important investor conference for life science in Europe and and we have been selected to present our innovative technology to the world. Schedule a partnering meeting with us to learn how we can boost your projects: https://conferences.biocentury.com/bioequity-europe/presenting-companies
February 10, 2021
Algenex selected as a finalist in Innovation Showcase
We have been selected to present our innovative technology in Animal Health Innovation Europe (February 22-23, 2021), the sector’s premier investment forum in Europe showcasing the most exciting innovators companies in animal health and nutrition. Schedule a partnering meeting with us to learn how w…
Algenex Frequently Asked Questions
When was Algenex founded?
Algenex was founded in 2005.
Who are Algenex key executives?
Algenex's key executives are José Escribano, Virginia Gonzalez and Romy Dalton.
How many employees does Algenex have?
Algenex has 25 employees.
Who are Algenex competitors?
Competitors of Algenex include Wings Therapeutics, Flash Therapeutics and Expansion Therapeutics.
Where is Algenex headquarters?
Algenex headquarters is located at Universidad Politécnica de Madrid, Av. de Montepríncipe, Madrid.
Where are Algenex offices?
Algenex has an office in Madrid.
How many offices does Algenex have?
Algenex has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies